Leveraging the Medicines for Malaria Venture malaria and pathogen boxes to discover chemical inhibitors of East Coast fever
Tài liệu tham khảo
Baldwin, 1988, Bovine T cells, B cells, and null cells are transformed by the protozoan parasite Theileria parva, Infect. Immun., 56, 462, 10.1128/iai.56.2.462-467.1988
Brown, 1990, Control of tropical theileriosis (Theileria annulata infection) of cattle, Parassitologia, 32, 23
Chen, 2006, Potent inhibition of platelet-derived growth factor-induced responses in vascular smooth muscle cells by BMS-354825 (dasatinib), Mol. Pharmacol., 69, 1527, 10.1124/mol.105.020172
Clinical Trials Partnership, 2015, Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial, Lancet (London, England), 386, 31, 10.1016/S0140-6736(15)60721-8
Comer, 2001, 275
Cui, 2015, Antimalarial drug resistance: literature review and activities and findings of the ICEMR network, Am. J. Trop. Med. Hyg., 93, 57, 10.4269/ajtmh.15-0007
Dobbelaere, 2003, Theileria-induced leukocyte transformation, Curr. Opin. Microbiol., 6, 377, 10.1016/S1369-5274(03)00085-7
Duffy, 2017, Screening the Medicines for malaria venture pathogen box across multiple pathogens reclassifies starting points for open-source drug discovery, Antimicrob. Agents Chemother., 61, 10.1128/AAC.00379-17
Fich, 1998, Modulation of enzymatic activity of Src-family kinases in bovine T cells transformed by Theileria parva, Parasitology, 117, 107, 10.1017/S0031182098002832
Finn, 2007, Dasatinib, an orally active small molecule inhibitor of both the src and abl kinases, selectively inhibits growth of basal-type/“triple-negative” breast cancer cell lines growing in vitro, Breast Canc. Res. Treat., 105, 319, 10.1007/s10549-006-9463-x
Hochhaus, 2008, Dasatinib induces durable cytogenetic responses in patients with chronic myelogenous leukemia in chronic phase with resistance or intolerance to imatinib, Leukemia, 22, 1200, 10.1038/leu.2008.84
Hostettler, 2016, In vitro screening of the open source MMV malaria box reveals novel compounds with profound activities against Theileria annulata schizonts, Antimicrob. Agents Chemother., 60, 3301, 10.1128/AAC.02801-15
Jeon, 2003, Gold compound auranofin inhibits IkappaB kinase (IKK) by modifying Cys-179 of IKKbeta subunit, Exp. Mol. Med., 35, 61, 10.1038/emm.2003.9
Johnson, 2010, Phase II study of dasatinib in patients with advanced non–small-cell lung cancer, J. Clin. Oncol., 28, 4609, 10.1200/JCO.2010.30.5474
McHardy, 1985, Antitheilerial activity of BW720C (buparvaquone): a comparison with parvaquone, Res. Vet. Sci., 39, 29, 10.1016/S0034-5288(18)31765-X
Metheni, 2015, HIF-1α induction, proliferation and glycolysis of Theileria-infected leukocytes, Cell Microbiol., 17, 467, 10.1111/cmi.12421
Mhadhbi, 2010, In vivo evidence for the resistance of Theileria annulata to buparvaquone, Vet. Parasitol., 169, 241, 10.1016/j.vetpar.2010.01.013
Morrison, 2009, Evolution of the Apicomplexa: where are we now?, Trends Parasitol., 25, 375, 10.1016/j.pt.2009.05.010
Nam, 2007, Dasatinib (BMS-354825) inhibits Stat5 signaling associated with apoptosis in chronic myelogenous leukemia cells, Mol. Canc. Therapeut., 6, 1400, 10.1158/1535-7163.MCT-06-0446
Nixon, 2013, Antimalarial pharmacology and therapeutics of atovaquone, J. Antimicrob. Chemother., 68, 977, 10.1093/jac/dks504
Norval, 1992
Oxberry, 2001, Assessment of benzimidazole binding to individual recombinant tubulin isotypes from Haemonchus contortus, Parasitology, 122, 683, 10.1017/S0031182001007788
Palacios, 1982, Concanavalin A triggers T lymphocytes by directly interacting with their receptors for activation, J. Immunol., 128, 337, 10.4049/jimmunol.128.1.337
Perry, 2016, The control of East Coast fever of cattle by live parasite vaccination: a science-to-impact narrative, One Health, 2, 103, 10.1016/j.onehlt.2016.07.002
Quintas-Cardama, 2006, Targeting ABL and SRC kinases in chronic myeloid leukemia: experience with dasatinib, Future Oncol. (London, England), 2, 655, 10.2217/14796694.2.6.655
Rigobello, 2005, Effect of auranofin on the mitochondrial generation of hydrogen peroxide. Role of thioredoxin reductase, Free Radic. Res., 39, 687, 10.1080/10715760500135391
Salas, 2011, Natural and synthetic naphthoquinones active against trypanosoma cruzi: an initial step towards new drugs for chagas disease, Curr. Med. Chem., 18, 144, 10.2174/092986711793979779
Sharifiyazdi, 2012, Point mutations in the Theileria annulata cytochrome b gene is associated with buparvaquone treatment failure, Vet. Parasitol., 187, 431, 10.1016/j.vetpar.2012.01.016
Shiels, 2006, Alteration of host cell phenotype by Theileria annulata and Theileria parva: mining for manipulators in the parasite genomes, Int. J. Parasitol., 36, 9, 10.1016/j.ijpara.2005.09.002
Steinberg, 2007, Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia, Clin. Therapeut., 29, 2289, 10.1016/j.clinthera.2007.11.005
Talpaz, 2006, Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias, N. Engl. J. Med., 354, 2531, 10.1056/NEJMoa055229
Vaidya, 2000, Atovaquone resistance in malaria parasites, Drug Resist. Updates, 3, 283, 10.1054/drup.2000.0157
Van Voorhis, 2016, Open source drug discovery with the malaria box compound collection for neglected diseases and beyond, PLoS Pathog., 12, e1005763, 10.1371/journal.ppat.1005763
Wampande, 2007, Classical ligands interact with native and recombinant tubulin from Onchocerca volvulus with similar rank order of magnitude, Protein Expr. Purif., 55, 236, 10.1016/j.pep.2007.04.011
